Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastomaRebecca C Abbott, Misty R. Jenkins|Clinical & Translational Immunology|2021Cited by 43
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie Shiqi Wang, Misty R. Jenkins|Neuro-Oncology Advances|2023Cited by 26